Non-Interventional Study About Treatment of Hemorrhages in Thyroid Surgery With TachoSil®

Nycomed

Status: Completed

Conditions: Hemorrhage

Study type: Observational

Funder types: Industry

Identifiers

NCT00700141

TC-031-DE

Details and patient eligibility

About

Considering the total number of thyroid procedures in Germany (100000 - 120000 cases per year), TachoSil® is a valuable tool to support surgical haemostasis, avoiding lymph leaks and support speech-nerve saving approaches. The aim of this study was to evaluate a patient and procedure profile where TachoSil® is most beneficial.

Enrollment: 482 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Main Inclusion Criteria:

• Patients undergoing total or subtotal thyroidectomy

Main Exclusion Criteria:

• Contraindications, such as hypersensitivity to the active pharmaceutical ingredient or to another ingredient